Stay updated on Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe history section shows Revision: v3.5.0 as the latest entry, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded revision entry: v3.4.3; removed revision: v3.4.2 from the history.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision history updated: added v3.4.2 and removed v3.4.1.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision: v3.4.1 was added to the history. The Notice about government funding and operating status was removed.SummaryDifference0.7%

- Check62 days agoChange DetectedA site-wide notice banner about a lapse in government funding and the NIH Clinical Center's operating status was added at the top of the page. The banner is informational and does not modify core trial data or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check69 days agoChange DetectedThe update adds a glossary display and color-coded highlights for additions (green) and deletions (red) in the study history, and updates the revision label to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

Stay in the know with updates to Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page.